-
Unique Focus and Experience
Daniel is a dual M&A and life sciences IP transactions lawyer with 20+ years of experience counseling multinational companies on cross-border M&A deals and complex commercial transactions.
Daniel Keating is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati.
Daniel is a dual M&A and life sciences IP transactions lawyer who counsels clients on M&A, licenses and collaborations, venture capital financings, and commercial transactions in the life sciences and technology sectors. Daniel has deep experience representing pharmaceutical, biotech and medical device companies, and investors on a broad range of transactions, including hybrid deals such as M&A transactions with back-end milestone payments, carve-outs, and product acquisitions/divestitures.
Daniel has 20+ years of legal experience and has counseled clients on over 500 completed M&A and other complex, strategic, and commercial transactions. He is also a former national champion powerlifter.
Daniel Keating is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati.
Daniel is a dual M&A and life sciences IP transactions lawyer who counsels clients on M&A, licenses and collaborations, venture capital financings, and commercial transactions in the life sciences and technology sectors. Daniel has deep experience representing pharmaceutical, biotech and medical device companies, and investors on a broad range of transactions, including hybrid deals such as M&A transactions with back-end milestone payments, carve-outs, and product acquisitions/divestitures.
Daniel has 20+ years of legal experience and has counseled clients on over 500 completed M&A and other complex, strategic, and commercial transactions. He is also a former national champion powerlifter.
- J.D., Georgetown University Law Center
- B.S., Michigan State UniversitySumma Cum Laude
- Selected for inclusion in the “Finance: Capital Markets: Equity Offerings” category in the 2017 edition of The Legal 500 US
- Selected for inclusion in the “Finance: Financial Services: Regulatory” category in the 2012 and 2014 editions of The Legal 500 US
- Recognized in the “Nationwide—Financial Services Regulation: Financial Institutions M&A” category in the 2010-2012 editions of Chambers USA: America's Leading Lawyers for Business
- Named in the “Mergers, Acquisitions, and Buyouts” category in the 2012 edition of The Legal 500 US
- Bar of the District of Columbia
- State Bar of New York
- J.D., Georgetown University Law Center
- B.S., Michigan State UniversitySumma Cum Laude
- Selected for inclusion in the “Finance: Capital Markets: Equity Offerings” category in the 2017 edition of The Legal 500 US
- Selected for inclusion in the “Finance: Financial Services: Regulatory” category in the 2012 and 2014 editions of The Legal 500 US
- Recognized in the “Nationwide—Financial Services Regulation: Financial Institutions M&A” category in the 2010-2012 editions of Chambers USA: America's Leading Lawyers for Business
- Named in the “Mergers, Acquisitions, and Buyouts” category in the 2012 edition of The Legal 500 US
- Bar of the District of Columbia
- State Bar of New York
Select Publications
- Co-author, “New SEC Guidance and PCAOB Auditing Standard No. 5 Provide Clarity on SOX Section 404,” Bloomberg Law Reports—Securities Law, September 17, 2007
- “End of an Era,” Legal Week Global, August 26, 2004
Select Publications
- Co-author, “New SEC Guidance and PCAOB Auditing Standard No. 5 Provide Clarity on SOX Section 404,” Bloomberg Law Reports—Securities Law, September 17, 2007
- “End of an Era,” Legal Week Global, August 26, 2004
The transaction is expected to be completed in the fourth quarter of 2023, subject to customary closing conditions. Subject to the terms and conditions of the agreement, following the completion of the tender offer, L Catterton will acquire any shares of Thorne that are not tendered in the tender offer through a second-step merger for $10.20 per share in cash. Upon completion of the transaction, Thorne will become a privately held company and its shares of common stock will no longer be listed on any public market.
The Wilson Sonsini team that represented Thorne and the Special Committee of the board of directors includes:
- Privacy Policy
- Terms of Use
- Accessibility